Replies to post #3007 on Windtree Therapeutics Inc (WINT)

[H2R]

The Achilles heel for WINT (as for some other small cap clinical stage company) was the balance sheet weakness. This should reassure investors that the Company is not going under.

My guess is that it will have a positive impact on the PPS!

Cheers!